RxDoctor Payments Data

Brooke Lavignette

Psychiatric/Mental Health · Lafayette, INNPI 1548875669

Payments from drug & device makers

$1,175in general payments, 2019–2025

Across 68 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$345
  • Teva Pharmaceuticals USA, Inc.$239
  • Alkermes, Inc.$112
  • Otsuka America Pharmaceutical, Inc.$98
  • Johnson & Johnson$91
  • Neurocrine Biosciences, Inc.$87
  • plus $202 from 8 others

What the payments were for

  • Food & beverage$1,175100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,175 in reported general payments places this provider in the 60th percentile of 729 psychiatric/mental health providers in Indiana.

See all psychiatric/mental health providers in Indiana

Medicare billing

Part B allowed, 2024
$22,267
Medicare patients
44
Services billed
329

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine57$355,785
Invega SustennaPaliperidone Palmitate92$301,822
IngrezzaValbenazine Tosylate31$233,731
Invega TrinzaPaliperidone Palmitate12$128,767
Abilify MaintenaAripiprazole30$83,288
VraylarCariprazine Hcl43$55,456
Paliperidone ErPaliperidone117$32,534
Aripiprazole134$31,984
RexultiBrexpiprazole14$19,413
LybalviOlanzapine/Samidorphan Malate13$18,447
SaphrisAsenapine Maleate13$13,976
Clozapine151$11,588
Lurasidone Hcl75$9,477
DayvigoLemborexant27$8,699
Olanzapine196$6,986

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza$91$430,589104 claims
Teva Pharmaceuticals USA, Inc.Austedo, Loxapine$239$357,00671 claims
Neurocrine Biosciences, Inc.Ingrezza$87$233,73131 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$98$102,70144 claims
AbbVieVraylar, Saphris$345$69,43256 claims
Alkermes, Inc.Lybalvi$112$18,44713 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$12$6,62214 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 729 psychiatric/mental health providers in Indiana.

Other psychiatric/mental health in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →